Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Markets flat despite stronger CPI reading
    • Market Update

    Markets flat despite stronger CPI reading

    The XJO is expected to open flat this morning following a meek rise in the U.S overnight. Their futures have edged into the green. We were expecting more of a reaction from the U.S last night considering their CPI numbers came in slightly higher than expected overall. Our hunch is they will have a delayed

    Read More
    Public
  • Retinal Eye Scanners: Restoring the lost hope for those who have lost vision
    • News

    Retinal Eye Scanners: Restoring the lost hope for those who have lost vision

    The eyes are the windows of the world, but for about one in seven Australians over the age of 50 years, they had no choice but to live with dark, blurry areas in the centre of their vision as a result of a condition called age-related Macular Degeneration (AMD).  Being the second leading cause of

    Read More
    Public
  • Packaging insider seizes on low ASX valuation in attempt to acquire Pact Group
    • News

    Packaging insider seizes on low ASX valuation in attempt to acquire Pact Group

    Packaging company Pact Group (ASX: PGH) appears to be seriously undervalued by investors which has prompted the Company’s Chairman to rustle up a bid to acquire the entire business.  The bid comes from Kin Group Ltd, an entity controlled by the Geminder family, of which Raphael Geminder is Chairman of Pact Group, and comprises an

    Read More
    Public
  • As dengue cases rise worldwide, Island gets US patent for its antiviral drug ISLA-101
    • News

    As dengue cases rise worldwide, Island gets US patent for its antiviral drug ISLA-101

    Nearly half of the world’s population is at risk of getting dengue, with cases expected to reach record highs this year. Sounding the alarm on its prevalence, the WHO dictates that there are about 100-400 million infections occurring each year. And global warming is to blame, creating a thriving environment for mosquitoes.  Dengue fever’s presence

    Read More
    Public
  • South African civil aviation approves RocketDNA’s drone product, Drone-in-a-Box
    • News

    South African civil aviation approves RocketDNA’s drone product, Drone-in-a-Box

    You’ve probably heard of the burger joint Jack-in-the-box, now meet its older and more advanced (and rather unrelated) sibling: Drone-in-a-Box by RocketDNA (ASX: RKT). The drone automation company’s ‘drone-in-a-box’ (comprising a drone inside a big box) can now operate in South Africa after receiving approval from the South African Civil Aviation Authority (SACAA) for Remote

    Read More
    Public
  • XJO to dip back below 7,200 after US selling
    • Market Update

    XJO to dip back below 7,200 after US selling

    The XJO is expected to edge lower on open this morning, following a small pullback in the U.S overnight. Their futures sit flat. Yesterday we managed to retake intraday losses to finish slightly in the green. Both the XJO and the U.S are consolidating sidewards with indecisive trading as we head into the U.S CPI

    Read More
    Public
  • «
  • ‹
  • 184
  • 185
  • 186
  • 187
  • 188
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.